Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1987 1
1988 1
2000 2
2003 1
2004 1
2006 3
2008 1
2009 1
2010 3
2011 8
2012 4
2013 5
2014 7
2015 5
2016 6
2017 3
2018 4
2019 8
2020 12
2021 23
2022 21
2023 29
2024 31
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Facon T, Dimopoulos MA, Leleu XP, Beksac M, Pour L, Hájek R, Liu Z, Minarik J, Moreau P, Romejko-Jarosinska J, Spicka I, Vorobyev VI, Besemer B, Ishida T, Janowski W, Kalayoglu-Besisik S, Parmar G, Robak P, Zamagni E, Goldschmidt H, Martin TG, Manier S, Mohty M, Oprea C, Brégeault MF, Macé S, Berthou C, Bregman D, Klippel Z, Orlowski RZ; IMROZ Study Group. Facon T, et al. Among authors: parmar g. N Engl J Med. 2024 Oct 31;391(17):1597-1609. doi: 10.1056/NEJMoa2400712. Epub 2024 Jun 3. N Engl J Med. 2024. PMID: 38832972 Clinical Trial.
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.
Moreau P, Dimopoulos MA, Mikhael J, Yong K, Capra M, Facon T, Hajek R, Špička I, Baker R, Kim K, Martinez G, Min CK, Pour L, Leleu X, Oriol A, Koh Y, Suzuki K, Risse ML, Asset G, Macé S, Martin T; IKEMA study group. Moreau P, et al. Lancet. 2021 Jun 19;397(10292):2361-2371. doi: 10.1016/S0140-6736(21)00592-4. Epub 2021 Jun 4. Lancet. 2021. PMID: 34097854 Clinical Trial.
Polycystic ovarian syndrome.
Madnani N, Khan K, Chauhan P, Parmar G. Madnani N, et al. Among authors: parmar g. Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):310-21. doi: 10.4103/0378-6323.110759. Indian J Dermatol Venereol Leprol. 2013. PMID: 23619436 Free article. Review.
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.
Ailawadhi S, Špička I, Spencer A, Lu J, Oriol A, Ling S, Schjesvold F, Berkovits A, Hus M, Li C, Dimopoulos MA, Rajnics P, Beşışık SK, Hungria V, Custidiano MDR, Parmar G, Leleu X, Li F, Cerchione C, Gomez C, Ishida T, Mateos MV, Buck TT, LeBlanc R, Minařík J, Goldschmidt H, Zhang R, Sémiond D, Suzan F, Stefanova-Urena M, Koch V, Moreau P. Ailawadhi S, et al. Among authors: parmar g. J Clin Oncol. 2025 Aug;43(22):2527-2537. doi: 10.1200/JCO-25-00744. Epub 2025 Jun 3. J Clin Oncol. 2025. PMID: 40459178 Clinical Trial.
Glycemic management during Jain fasts.
Julka S, Sachan A, Bajaj S, Sahay R, Chawla R, Agrawal N, Saboo B, Unnikrishnan AG, Baruah MP, Parmar G, Kalra S. Julka S, et al. Among authors: parmar g. Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):238-241. doi: 10.4103/2230-8210.192489. Indian J Endocrinol Metab. 2017. PMID: 28217525 Free PMC article. Review.
Radiation-Induced Lung Injury-Current Perspectives and Management.
Rahi MS, Parekh J, Pednekar P, Parmar G, Abraham S, Nasir S, Subramaniyam R, Jeyashanmugaraja GP, Gunasekaran K. Rahi MS, et al. Among authors: parmar g. Clin Pract. 2021 Jul 1;11(3):410-429. doi: 10.3390/clinpract11030056. Clin Pract. 2021. PMID: 34287252 Free PMC article. Review.
A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma.
Quach H, Parmar G, Ocio EM, Prince HM, Oriol A, Crowther H, Tsukada N, Bories P, Madan S, Nathwani N, Sunami K, Semiond D, Yu D, Cordero P, Macé S, Suzan F, Moreau P. Quach H, et al. Among authors: parmar g. Haematologica. 2024 Dec 1;109(12):4078-4082. doi: 10.3324/haematol.2023.284730. Haematologica. 2024. PMID: 39157871 Free PMC article. No abstract available.
The Changing Face of Primary Hyperparathyroidism.
Parmar G, Chadha M. Parmar G, et al. Indian J Endocrinol Metab. 2018 May-Jun;22(3):299-300. doi: 10.4103/2230-8210.236781. Indian J Endocrinol Metab. 2018. PMID: 30090717 Free PMC article. No abstract available.
The DA Vinci Diet.
Parmar G, Shaikh S, Joshi A, Kalra S. Parmar G, et al. J Pak Med Assoc. 2018 Nov;68(11):1724-1726. J Pak Med Assoc. 2018. PMID: 30410161
174 results